Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study

Detalles Bibliográficos
Autores principales: Georgakopoulos, Jorge R., Felfeli, Tina, Drucker, Aaron M., Jo, Christine E., Piguet, Vincent, Yeung, Jensen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362263/
https://www.ncbi.nlm.nih.gov/pubmed/34409396
http://dx.doi.org/10.1016/j.jdin.2021.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362263/
https://www.ncbi.nlm.nih.gov/pubmed/34409396
http://dx.doi.org/10.1016/j.jdin.2021.06.001

Ejemplares similares